Pricing Log in Create free account

LeonaBio, Inc. (LONA) vs Serina Therapeutics, Inc. (SER)

LeonaBio, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. LeonaBio, Inc. and Serina Therapeutics, Inc. are of similar size ($41.9M and $40.9M). Across the 10 metrics below, Serina Therapeutics, Inc. leads on 6 and LeonaBio, Inc. on 4.

Valuation

Metric LONA SER Biotechnology median
P/E n/m n/m 10.60
P/S n/m 126.73 9.40
P/B 3.12 1.22 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 32.54 9.02
Earnings yield (522.84%) (135.00%) (32.88%)
Free cash flow yield (59.08%) (92.42%) (23.13%)

Profitability

Metric LONA SER Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (431.39%) (306.22%) (51.96%)
Return on assets (306.05%) (136.00%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LONA SER Biotechnology median
Revenue growth (TTM) — (94.21%) 6.76%
EPS growth (last fiscal year) 1.98% (26.49%) 29.88%
Revenue growth, 5-year CAGR — (18.48%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LONA SER Biotechnology median
Debt to equity 0.00 0.16 0.00
Current ratio 7.01 6.65 4.97
Net debt to EBITDA 0.87 0.00 1.01

Dividend

Metric LONA SER Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LONA SER Biotechnology median
Market cap 40.89m 41.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack